Evidence map›Paper›PMID 22473615›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2012

Positive allosteric modulators differentially affect full versus partial agonist activation of the glycine receptor.

Dean Kirson, Jelena Todorovic, S John Mihic

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Intermediate closed state for glycine receptor function revealed by cysteine cross-linking.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dean KirsonWaggoner Center for Alcohol and Addiction Research, and Institute for Neuroscience, University of Texas at Austin, Austin, Texas, USA.
Jelena Todorovic
S John Mihic
The University of Texas at Austin · US

Funding

In vitro screening of novel therapeutic agents for the treatment of alcohol abuseR03AA018197 · NIAAA · UNIVERSITY OF TEXAS AT AUSTIN · PI MIHIC, S JOHN · 2009 to 2010
$143k
NIAAA NIH HHS 1R03AA018197NIAAA NIH HHS R03 AA018197
6 · The paper itself

Abstract

Taurine acts as a partial agonist at the glycine receptor (GlyR) in some brain regions such as the hippocampus, striatum, and nucleus accumbens. Ethanol, volatile anesthetics, and inhaled drugs of abuse are all known positive allosteric modulators of GlyRs, but their effects on taurine-activated GlyRs remain poorly understood, especially their effects on the high concentrations of taurine likely to be found after synaptic release. Two-electrode voltage-clamp electrophysiology in Xenopus laevis oocytes was used to compare the enhancing effects of ethanol, anesthetics, and inhalants on human homomeric α1-GlyR activated by saturating concentrations of glycine versus taurine. Allosteric modulators had negligible effects on glycine-activated GlyR while potentiating taurine-activated currents. In addition, inhaled anesthetics markedly enhanced desensitization rates of taurine- but not glycine-activated receptors. Our findings suggest that ethanol, volatile anesthetics, and inhalants differentially affect the time courses of synaptic events at GlyR, depending on whether the receptor is activated by a full or partial agonist.

Indexed as

Allosteric RegulationAnestheticsAnimalsDrug Partial AgonismEthanolGlycineOocytesReceptors, GlycineTaurineXenopus laevisAnestheticsEthanolGlycineReceptors, GlycineTaurine

Identifiers

PMID22473615
PMCPMC3383033
OpenAlexW2136047477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.